Orthopaedic Surgery·Chicago, IL

University of Chicago

Signal lift2%24%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
245–272
p10 – p90
Sample N
584
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.9%
5 of 74 applicants
01Cohort funnelthis cycle
N = 584
Applied
584
100.0%
Invited
74
12.7%
Class size
5
0.9%
02Away rotation impact
+74pp lift
Non-rotators
12%
68 of 577
Rotators
86%
6 of 7
Interview lift
+74pp
vs not rotating

Of 7 prior-cycle rotators, 85% got an interview vs 11% for the wider applicant pool here. Rotation appears to materially shift interview odds at this program.

J-1 visaH-1B visaF-1 visaCategorical
Your fitUniversity of Chicago Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at University of Chicago Program

Create free account
Contact
TB
Program Director
Tessa Balach, MD
Email director
AD
Program Coordinator
Annie Detrick, BFA
Email coordinator
Training sites4 hospitals
  • 1
    University of Chicago Medical Center
    Chicago, IL
    Primary
  • 2
    Louis A Weiss Memorial Hospital
    Chicago, IL
    Participant
  • 3
    Evanston Hospital-Northshore University Health System
    Evanston, IL
    Participant
  • 4
    Loyola University Medical Center
    Maywood, IL
    Participant
Interview invites
Loading...
Rotator reports6 reports · paraphrased
hands-on
  • 19-20Rotator in 2019/20 described a laid-back rotation (two services for two weeks each), multiple fellows in hand, joints, onc, and sports, well-regarded morning conferences and weekly didactics, and a brief on-service interview during the rotation. Post-call days off for students. Research infrastructure was noted as limited.
  • 18-19Two rotators in 2018/19 described new level-1 trauma designation expected to strengthen training, well-regarded facilities, strong fellowship match, and a close resident group. Rotators described rising program momentum in the Chicagoland area.
  • 17-18Two rotators in 2017/18 described substantial recent change including leadership transitions, division-to-department restructuring, and a new level-1 trauma center opening in 2018. Operative setup was described as a PGY5 walking PGY2 through cases. Rotators noted an approachable chair and uncertainty about program trajectory.
  • 15-16Rotator in 2015/16 described strong faculty support for resident education, a modern primary hospital, manageable call, and well-regarded fellowship placement. Rotating through Loyola and North Shore for trauma was noted as a logistical downside.

Paraphrased from rotator survey responses. Names and identifying details removed.

Score rangesinvited cohort
USMLE Step 2 CK245272
180205230255280

Level 2 CE data not available

Interview rates
US MD
14%
US DO
4%
US IMG
0%
Non-US IMG
0%
Applicant origin
In-state
30%
Out-of-state
11%
Interview prepOrthopaedic Surgery
specialtyWhy orthopaedics over general surgery?★ common
clinicalDescribe an orthopaedic case that was memorable to you.★ common
specialtyWhat subspecialty are you considering? (Sports, spine, trauma, hand, joints)★ common
behavioralHow do you maintain work-life balance in a surgical specialty?
clinicalTell me about your surgical experience.★ common
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesOrthopaedic Surgery · 25-26
Save this program

Add University of Chicago to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Orthopaedic Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.